Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Parvaneh Baghaei Shiva (Tehran, Islamic Republic of Iran), Parvaneh Baghaei, Payam Tabarsi, Mohammad Reza Masjdei. Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus. Eur Respir J 2015; 46: Suppl. 59, 2705

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Efficacy of moxifloxacin in TB resistant to isoniazid Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Screening of diabetes mellitus among new cases of tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Clinical experience of clofazimine in the treatment of MDR-TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Effectiveness of lung surgery in MDR TB patients with diabetes mellitus Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Reduced moxifloxacin exposure in patients with tuberculosis and diabetes Source: Eur Respir J, 54 (3) 1900373; 10.1183/13993003.00373-2019 Year: 2019 Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Influence of diabetes mellitus on sputum conversion rate in pulmonary tuberculosis and on antituberculous drug resistance Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012